From shape to cells: Mouse models reveal mechanisms altering palate development in Apert syndrome

DMM Disease Models and Mechanisms

Volumn 6, Issue 3, 2013, Pages 768-779

  Martínez Abadías, Neus ^a,c   Holmes, Greg ^b   Pankratz, Talia ^a   Wang, Yingli ^b   Zhou, Xueyan ^b   Jabs, Ethylin Wang ^b   Richtsmeier, Joan T ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2;

ACROCEPHALOSYNDACTYLY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLEFT PALATE; GENE MUTATION; IMMUNOHISTOCHEMISTRY; MISSENSE MUTATION; MORPHOMETRICS; MOUSE; NEWBORN; NONHUMAN; ORGANOGENESIS; PALATE; PHENOTYPE; PRIORITY JOURNAL; TERATOLOGY;

ACROCEPHALOSYNDACTYLIA; ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, INBRED C57BL; MUTATION; PALATE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2;

EID: 84877839992     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.010397     Document Type: Article

References (53)

1. Abu-Issa, R., Smyth, G., Smoak, I., Yamamura, K. and Meyers, E. N. (2002). Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development 129, 4613-4625.
2. Aldridge, K., Hill, C. A., Austin, J. R., Percival, C., Martínez-Abadias, N., Neuberger, T., Wang, Y., Jabs, E. W. and Richtsmeier, J. T. (2010). Brain phenotypes in two FGFR2 mouse models for Apert syndrome. Dev. Dyn. 239, 987-997.
3. Bachler, M. and Neubüser, A. (2001). Expression of members of the Fgf family and their receptors during midfacial development. Mech. Dev. 100, 313-316.
4. Britto, J. A., Evans, R. D., Hayward, R. D. and Jones, B. M. (2002). Toward pathogenesis of Apert cleft palate: FGF, FGFR, and TGF beta genes are differentially expressed in sequential stages of human palatal shelf fusion. Cleft Palate Craniofac. J. 39, 332-340.
5. Chen, L., Li, D., Li, C., Engel, A. and Deng, C. X. (2003). A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 33, 169-178.
6. Cohen, M. M., Jr and Kreiborg, S. (1996). A clinical study of the craniofacial features in Apert syndrome. Int. J. Oral Maxillofac. Surg. 25, 45-53.
7. Cohen, M. J. and MacLean, R. (2000). Craniosynostosis: diagnosis, evaluation, and management. J. Med. Genet. 37, 727.
8. Cole, T., III, (2002). WinEDMA Version 1.0.1 beta. Windows-Based Software for Euclidean distance Matrix Analysis.
9. De Moerlooze, L., Spencer-Dene, B., Revest, J. M., Hajihosseini, M., Rosewell, I. and Dickson, C. (2000). An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 127, 483-492.
10. Dixon, M. J., Marazita, M. L., Beaty, T. H. and Murray, J. C. (2011). Cleft lip and palate: understanding genetic and environmental influences. Nat. Rev. Genet. 12, 167-178.
11. Dorey, K. and Amaya, E. (2010). FGF signalling: diverse roles during early vertebrate embryogenesis. Development 137, 3731-3742.
12. Drake, A. G. and Klingenberg, C. P. (2008). The pace of morphological change: historical transformation of skull shape in St Bernard dogs. Proc. Biol. Sci. 275, 71-76.
13. Dryden, I. and Mardia, K. (1998). Statistical Shape Analysis. Chichester, UK: John Wiley.
14. Du, X., Weng, T., Sun, Q., Su, N., Chen, Z., Qi, H., Jin, M., Yin, L., He, Q. and Chen, L. (2010). Dynamic morphological changes in the skulls of mice mimicking human Apert syndrome resulting from gain-of-function mutation of FGFR2 (P253R). J. Anat. 217, 97-105.
15. Gritli-Linde, A. (2007). Molecular control of secondary palate development. Dev. Biol. 301, 309-326.
16. Hajihosseini, M. K. and Heath, J. K. (2002). Expression patterns of fibroblast growth factors-18 and -20 in mouse embryos is suggestive of novel roles in calvarial and limb development. Mech. Dev. 113, 79-83.
17. Hajihosseini, M. K., Lalioti, M. D., Arthaud, S., Burgar, H. R., Brown, J. M., Twigg, S. R. F., Wilkie, A. O. M. and Heath, J. K. (2004). Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics. Development 131, 325-335.
18. Hajihosseini, M. K., Duarte, R., Pegrum, J., Donjacour, A., Lana-Elola, E., Rice, D. P., Sharpe, J. and Dickson, C. (2009). Evidence that Fgf10 contributes to the skeletal and visceral defects of an Apert syndrome mouse model. Dev. Dyn. 238, 376-385.
19. Hébert, J. M. (2011). FGFs: neurodevelopment's Jack-of-all-trades - how do they do it? Front. Neurosci. 5, 133.
20. Holmes, G. and Basilico, C. (2012). Mesodermal expression of Fgfr2S252W is necessary and sufficient to induce craniosynostosis in a mouse model of Apert syndrome. Dev. Biol. 368, 283-293.
21. Holmes, G., Rothschild, G., Roy, U. B., Deng, C. X., Mansukhani, A. and Basilico, C. (2009). Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology. Dev. Biol. 328, 273-284.
22. Ibrahimi, O. A., Eliseenkova, A. V., Plotnikov, A. N., Yu, K., Ornitz, D. M. and Mohammadi, M. (2001). Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc. Natl. Acad. Sci. USA 98, 7182-7187.
23. Iwata, J., Parada, C. and Chai, Y. (2011). The mechanism of TGF-β signaling during palate development. Oral Dis. 17, 733-744.
24. Klingenberg, C. P. (2011). MorphoJ: an integrated software package for geometric morphometrics. Mol. Ecol. Resour. 11, 353-357.
25. Klingenberg, C. P. and Monteiro, L. R. (2005). Distances and directions in multidimensional shape spaces: implications for morphometric applications. Syst. Biol. 54, 678-688.
26. Kreiborg, S. and Cohen, M. M., Jr (1992). The oral manifestations of Apert syndrome. J. Craniofac. Genet. Dev. Biol. 12, 41-48.
27. Lele, S. and Richtsmeier, J. T. (1995). Euclidean distance matrix analysis: confidence intervals for form and growth differences. Am. J. Phys. Anthropol. 98, 73-86.
28. Lele, S. and Richtsmeier, J. T. (2001). An Invariant Approach to the Statistical Analysis of Shapes. Boca Raton, FL: Chapman and Hall/CRC Press.
29. Liu, Z., Xu, J., Colvin, J. S. and Ornitz, D. M. (2002). Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev. 16, 859-869.
30. Manly, B. F. J. (2004). Multivariate Statistical Methods: A Primer, Third Edition. Boca Raton, FL: Chapman and Hall/CRC.
31. Mansukhani, A., Bellosta, P., Sahni, M. and Basilico, C. (2000). Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J. Cell Biol. 149, 1297-1308.
32. Martínez-Abadías, N., Percival, C., Aldridge, K., Hill, C. A., Ryan, T., Sirivunnabood, S., Wang, Y., Jabs, E. W. and Richtsmeier, J. T. (2010). Beyond the closed suture in apert syndrome mouse models: evidence of primary effects of FGFR2 signaling on facial shape at birth. Dev. Dyn. 239, 3058-3071.
33. Martínez-Abadías, N., Heuzé, Y., Wang, Y., Jabs, E. W., Aldridge, K. and Richtsmeier, J. T. (2011). FGF/FGFR signaling coordinates skull development by modulating magnitude of morphological integration: evidence from Apert syndrome mouse models. PLoS ONE 6, e26425.
34. Martínez-Abadías, N., Motch, S. M., Pankratz, T. L., Wang, Y., Aldridge, K., Jabs, E. W. and Richtsmeier, J. T. (2013). Tissue-specific responses to aberrant FGF signaling in complex head phenotypes. Dev. Dyn. 242, 80-94.
35. Miao, D. and Scutt, A. (2002). Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J. Histochem. Cytochem. 50, 333-340.
36. Mossey, P. A., Little, J., Munger, R. G., Dixon, M. J. and Shaw, W. C. (2009). Cleft lip and palate. Lancet 374, 1773-1785.
37. Ohbayashi, N., Shibayama, M., Kurotaki, Y., Imanishi, M., Fujimori, T., Itoh, N. and Takada, S. (2002). FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 16, 870-879.
38. Ornitz, D. M. and Marie, P. J. (2002). FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16, 1446-1465.
39. Park, W. J., Theda, C., Maestri, N. E., Meyers, G. A., Fryburg, J. S., Dufresne, C., Cohen, M. M., Jr and Jabs, E. W. (1995). Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am. J. Hum. Genet. 57, 321-328.
40. Purushothaman, R., Cox, T. C., Muga, A. M. and Cunningham, M. L. (2011). Facial suture synostosis of newborn Fgfr1(P250R/+) and Fgfr2(S252W/+) mouse models of Pfeiffer and Apert syndromes. Birth Defects Res. A Clin. Mol. Teratol. 91, 603-609.
41. Rice, D. P., Rice, R. and Thesleff, I. (2003). Fgfr mRNA isoforms in craniofacial bone development. Bone 33, 14-27.
42. Rice, R., Spencer-Dene, B., Connor, E. C., Gritli-Linde, A., McMahon, A. P., Dickson, C., Thesleff, I. and Rice, D. P. (2004). Disruption of Fgf10/Fgfr2b-coordinated epithelial-mesenchymal interactions causes cleft palate. J. Clin. Invest. 113, 1692-1700.
43. Riley, B. M., Mansilla, M. A., Ma, J., Daack-Hirsch, S., Maher, B. S., Raffensperger, L. M., Russo, E. T., Vieira, A. R., Dodé, C., Mohammadi, M. et al. (2007). Impaired FGF signaling contributes to cleft lip and palate. Proc. Natl. Acad. Sci. USA 104, 4512-4517.
44. Shukla, V., Coumoul, X., Wang, R.-H., Kim, H.-S. and Deng, C.-X. (2007). RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. Nat. Genet. 39, 1145-1150.
45. Slaney, S. F., Oldridge, M., Hurst, J. A., Moriss-Kay, G. M., Hall, C. M., Poole, M. D. and Wilkie, A. O. (1996). Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome. Am. J. Hum. Genet. 58, 923-932.
46. Snyder-Warwick, A. K., Perlyn, C. A., Pan, J., Yu, K., Zhang, L. and Ornitz, D. M. (2010). Analysis of a gain-of-function FGFR2 Crouzon mutation provides evidence of loss of function activity in the etiology of cleft palate. Proc. Natl. Acad. Sci. USA 107, 2515-2520.
47. Trokovic, N., Trokovic, R., Mai, P. and Partanen, J. (2003). Fgfr1 regulates patterning of the pharyngeal region. Genes Dev. 17, 141-153.
48. Wang, Y., Xiao, R., Yang, F., Karim, B. O., Iacovelli, A. J., Cai, J., Lerner, C. P., Richtsmeier, J. T., Leszl, J. M., Hill, C. A. et al. (2005). Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse. Development 132, 3537-3548.
49. Wang, Y., Sun, M., Uhlhorn, V. L., Zhou, X., Peter, I., Martínez-Abadias, N., Hill, C. A., Percival, C. J., Richtsmeier, J. T., Huso, D. L. et al. (2010). Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice. BMC Dev. Biol. 10, 22.
50. Welsh, I. C., Hagge-Greenberg, A. and O'Brien, T. P. (2007). A dosage-dependent role for Spry2 in growth and patterning during palate development. Mech. Dev. 124, 746-761.
51. Wilke, T. A., Gubbels, S., Schwartz, J. and Richman, J. M. (1997). Expression of fibroblast growth factor receptors (FGFR1, FGFR2, FGFR3) in the developing head and face. Dev. Dyn. 210, 41-52.
52. Wilkie, A. O., Slaney, S. F., Oldridge, M., Poole, M. D., Ashworth, G. J., Hockley, A. D., Hayward, R. D., David, D. J., Pulleyn, L. J., Rutland, P. et al. (1995). Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat. Genet. 9, 165-172.
53. Yu, K. and Ornitz, D. M. (2011). Histomorphological study of palatal shelf elevation during murine secondary palate formation. Dev. Dyn. 240, 1737-1744.